In summary, our findings indicate that FXN plays a significant role in the development of DOX mediated myocardial iron overload and that PAESe protects FXN from the impaired mitochondrial bioenergetics leading to progression of de-compensatory cardiomyopathy. Here, FXN is linked to cardiomyopathy.